Lyra Therapeutics, Inc. (LYRA)
NASDAQ: LYRA · Real-Time Price · USD
0.180
+0.010 (5.88%)
At close: Dec 20, 2024, 4:00 PM
0.183
+0.003 (1.67%)
After-hours: Dec 20, 2024, 7:31 PM EST

Lyra Therapeutics Revenue

Lyra Therapeutics had revenue of $195.00K in the quarter ending September 30, 2024, a decrease of -64.15%. This brings the company's revenue in the last twelve months to $1.47M, up 3.37% year-over-year. In the year 2023, Lyra Therapeutics had annual revenue of $1.56M with 14.31% growth.

Revenue (ttm)
$1.47M
Revenue Growth
+3.37%
P/S Ratio
7.85
Revenue / Employee
$16,716
Employees
88
Market Cap
11.78M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 20231.56M195.00K14.31%
Dec 31, 20221.36M1.08M378.25%
Dec 31, 2021285.00K--
Dec 31, 2020---
Dec 31, 2019---
Dec 31, 2018 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Cosmos Health 56.04M
STRATA Skin Sciences 32.68M
Sol-Gel Technologies 11.71M
Immuron 3.27M
AIM ImmunoTech 190.00K
Revenue Rankings